Loading...
XASX
TRJ
Market cap75mUSD
Jul 08, Last price  
0.76AUD
1D
1.74%
1Q
-11.11%
IPO
-63.11%
Name

Trajan Group Holdings Ltd

Chart & Performance

D1W1MN
P/E
P/S
0.75
EPS
Div Yield, %
Shrs. gr., 5y
3.30%
Rev. gr., 5y
18.00%
Revenues
155m
-4.40%
54,293,00057,193,00067,766,00071,852,00076,568,000107,574,000162,154,000155,023,000
Net income
-25m
L
691,0001,448,0002,142,0002,620,0001,880,0001,704,0001,889,000-25,329,000
CFO
9m
-0.80%
2,107,0001,694,0002,839,0001,761,0009,448,0002,134,0009,551,0009,475,000

Profile

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through two segments, Analytical Products and Life Science Solutions. It offers analytical products, including syringes, GC consumables, septas, caps, liners, gas filters, and tubing products; pathology solutions; and sampling products, as well as automation systems for the analysis of biological, food, and environmental samples. The company also provides nutrition testing solutions for pathology laboratories, research and clinical trials, personalized nutrition, corporate wellness, and health insurance. In addition, it offers automation workflow solutions, micro sampling devices, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.
IPO date
Jun 07, 2021
Employees
653
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
155,023
-4.40%
162,154
50.74%
Cost of revenue
189,917
186,923
Unusual Expense (Income)
NOPBT
(34,894)
(24,769)
NOPBT Margin
Operating Taxes
(5,779)
3,586
Tax Rate
NOPAT
(29,115)
(28,355)
Net income
(25,329)
-1,440.87%
1,889
10.86%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,346
BB yield
-1.57%
Debt
Debt current
45,975
11,762
Long-term debt
22,249
60,380
Deferred revenue
10,837
Other long-term liabilities
387
549
Net debt
56,844
59,554
Cash flow
Cash from operating activities
9,475
9,551
CAPEX
(3,040)
(8,553)
Cash from investing activities
(3,040)
(8,553)
Cash from financing activities
(6,400)
(3,364)
FCF
(19,071)
(43,989)
Balance
Cash
11,243
11,038
Long term investments
137
1,550
Excess cash
3,629
4,480
Stockholders' equity
102,849
129,529
Invested Capital
155,770
186,903
ROIC
ROCE
EV
Common stock shares outstanding
152,201
153,295
Price
1.02
-43.65%
1.81
-9.50%
Market cap
155,245
-44.05%
277,464
2.11%
EV
212,089
337,018
EBITDA
(34,894)
(19,407)
EV/EBITDA
Interest
4,536
4,024
Interest/NOPBT